Atara Biotherapeutics Inc logo

Atara Biotherapeutics Inc

$ 14.82 (0%) Sep 30
P/E:
At Loss
P/B:
1.38
Market Cap:
$ 356.69M
Enterprise V:
$ 89.38M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
356.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
89.38M
PB Ratio:
1.38
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs.
Name Current Vs Industry Vs History
Cash-To-Debt 5.18
Equity-to-Asset 0.59
Debt-to-Equity 0.25
Debt-to-EBITDA -0.22
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.71
Distress
Grey
Safe
Beneish M-Score 5.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.28
Quick Ratio 5.28
Cash Ratio 5.04
Days Sales Outstanding 3.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.9

Financials (Next Earnings Date:2022-11-04 Est.)

LTS:0HIY's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 71.811
EPS (TTM) ($) -2.55
Beta 0.99
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 14.821
12-1 Month Momentum % 0
52-Week Range ($) 14.821 - 14.821
Shares Outstanding (Mil) 94.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Atara Biotherapeutics Inc Filings

Document Form Filing Date
No Filing Data

Atara Biotherapeutics Inc Analysis

Share your research